| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 06/27/2013 | US20130165475 Deuterium-enriched heterocyclic compounds as kinase inhibitors |
| 06/27/2013 | US20130165472 Heteroaryls and uses thereof |
| 06/27/2013 | US20130165464 Heteroaryls and uses thereof |
| 06/27/2013 | US20130165450 Novel Thiazol-Carboximide Derivatives as PDK1 Inhibitors |
| 06/27/2013 | US20130165449 Compounds and Method for Treatment of Cancer |
| 06/27/2013 | US20130165447 Inhibitors of PDE10 |
| 06/27/2013 | US20130165446 Benzo-or pyrido-imidazole derivative |
| 06/27/2013 | US20130165440 JAK1 Inhibitors |
| 06/27/2013 | US20130165439 Chemical compounds |
| 06/27/2013 | US20130165437 Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders. |
| 06/27/2013 | US20130165431 Inhibitors of syk and jak protein kinases |
| 06/27/2013 | US20130165426 Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators |
| 06/27/2013 | US20130165424 Dispiropyrrolidine derivatives |
| 06/27/2013 | US20130165415 Chemical compounds |
| 06/27/2013 | US20130164259 1,4-substituted piperazine derivatives and methods of use thereof |
| 06/27/2013 | US20130161591 Material for organic electroluminescent element, and organic electroluminescent element |
| 06/27/2013 | CA2858123A1 [1,2,4]triazolopyridines and their use as phospodiesterase inhibitors |
| 06/27/2013 | CA2854248A1 2,4-diamine-pyrimidine derivative as serine/threonine kinase inhibitors |
| 06/26/2013 | EP2607365A1 Toll-like receptor modulators and treatment of diseases |
| 06/26/2013 | EP2607364A1 Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators |
| 06/26/2013 | EP2607363A1 Fused ring compound for use as mineralocorticoid receptor antagonist |
| 06/26/2013 | EP2606051A1 Pyrrolopyrimidine compounds and uses thereof |
| 06/26/2013 | EP2606049A2 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 06/26/2013 | EP2606048A1 Fluoroalkylation methods and reagents |
| 06/26/2013 | EP2606047A1 Lipidated immune response modifier compound compositions, formulations, and methods |
| 06/26/2013 | EP2606046A1 2-(arylamino)-3h-imidazo[4,5-b]pyridine-6-carboxamide derivatives and their use as mpges-1 inhibitors |
| 06/26/2013 | EP2606045A1 Oxadiazole inhibitors of leukotriene production |
| 06/26/2013 | EP2606032A2 Composition and methods for treating glioblastoma |
| 06/26/2013 | EP2606025A1 Process for preparing a propiolic acid or a derivative thereof |
| 06/26/2013 | CN103180321A Monohydrate of azaadamantane derivative |
| 06/26/2013 | CN103180320A 1H-pyrrolo[2,3-b]pyridine derivatives |
| 06/26/2013 | CN103180319A Inhibitors of semicarabazide - sensitive amine oxidase |
| 06/26/2013 | CN103180318A Male contraceptive compositions and methods of use |
| 06/26/2013 | CN103180314A Oxadiazole inhibitors of leukotriene production |
| 06/26/2013 | CN103180313A 有机电致发光装置 Organic electroluminescent device |
| 06/26/2013 | CN103180312A Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine |
| 06/26/2013 | CN103180310A Hetero-bicyclic derivatives as hcv inhibitors |
| 06/26/2013 | CN103180308A Novel method of preparing benzoimidazole derivatives |
| 06/26/2013 | CN103180296A Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
| 06/26/2013 | CN103172776A Fluorescent star-like polymer as well as preparation method and application thereof |
| 06/26/2013 | CN103172641A Heterocyclic amino and alkoxy-replaced quinazoline derivative and application thereof |
| 06/26/2013 | CN103172632A Reaction product of stannyl derivative of naphthalimide and rylene |
| 06/26/2013 | CN103172631A Condensed pyrimidine derivative serving as transient receptor potential vanilla 3 (TRRV3) regulator |
| 06/26/2013 | CN103172630A Phenanthroline-containing organic semiconductor material and preparation method thereof and organic electroluminescent device |
| 06/26/2013 | CN103172629A Synthesis method of high-purity moxifloxacin hydrochloride |
| 06/26/2013 | CN102196809B Agent for treatment of diabetic nephropathy |
| 06/26/2013 | CN102180878B Dolasetron isomer or salt thereof, preparation method for the Dolasetron isomer or salt thereof and application of the Dolasetron isomer or salt thereof |
| 06/26/2013 | CN101912400B 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido[2,3-d] pyrimidine derivatives and related compounds for the treatment of cancer |
| 06/26/2013 | CN101389338B 双环杂芳基化合物 Bicyclic heteroaryl compound |
| 06/25/2013 | US8471027 Adamantyl compounds |
| 06/25/2013 | US8471026 Substituted hydroxamic acids and uses thereof |
| 06/25/2013 | US8471020 Perylene-based semiconducting materials |
| 06/25/2013 | US8471008 Material for organic electroluminescent element and organic electroluminescent element employing the same |
| 06/25/2013 | US8470854 Lactam-containing compounds and derivatives thereof as factor XA inhibitors |
| 06/25/2013 | US8470848 Organic compounds |
| 06/25/2013 | US8470847 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 06/25/2013 | US8470844 Imidazoacridinone derivative compounds and methods for their use |
| 06/25/2013 | US8470843 Azacyclic compounds |
| 06/25/2013 | US8470836 Dipeptidyl peptidase-IV inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as active agent |
| 06/25/2013 | US8470821 PDE4B inhibitors and uses therefor |
| 06/25/2013 | CA2576850C Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 06/25/2013 | CA2547814C Spiropiperidine derivatives for controlling pests |
| 06/22/2013 | CA2762717A1 Antimicrobial agents |
| 06/20/2013 | WO2013090840A1 2 -amino- pyrido [3, 2 -d] pyrimidine derivatives as hcv inhibitors |
| 06/20/2013 | WO2013088257A1 Substituted heterocyclic compounds as tropomyosin receptor kinase a (trka) inhibitors |
| 06/20/2013 | WO2013088256A1 Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (trk) inhibitors |
| 06/20/2013 | WO2013087965A1 Scorpion‑tail-like macrocyclic compounds and use thereof as antiparasitic agents |
| 06/20/2013 | WO2013087933A1 Cationic tetrahydropyrazolopyridines, dye composition comprising such oxidation bases, implementation process therefor and use thereof |
| 06/20/2013 | WO2013087932A1 Coupler with 7-amino-1,2,3,4-tetrahydroquinoline structure, dyeing composition comprising same, processes and uses |
| 06/20/2013 | WO2013087805A1 Piperazine derivatives and their use as positive allosteric modulators of mglu5 receptors |
| 06/20/2013 | WO2013087744A1 Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof |
| 06/20/2013 | WO2013087579A1 Substituted triazolopyridines and their use as ttk inhibitors |
| 06/20/2013 | WO2013086935A1 Method for synthesizing 1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-formamidine hydrochloride |
| 06/20/2013 | WO2013057013A3 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 06/20/2013 | WO2013056003A3 Catechol diethers as potent anti-hiv agents |
| 06/20/2013 | US20130158269 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 06/20/2013 | US20130158259 2-aminopyrimidine modulators of the histamine h4 receptor |
| 06/20/2013 | US20130158258 2-aminopyrimidine modulators of the histamine h4 receptor |
| 06/20/2013 | US20130158068 Dicarboximide derivatives of berbamine, the preparation and use thereof |
| 06/20/2013 | US20130158066 4-azaindole inhibitors of crac |
| 06/20/2013 | US20130158063 Compounds, Compositions and Methods Related to PPAR Antagonists |
| 06/20/2013 | US20130158056 Alkoxy pyrimidine pde10 inhibitors |
| 06/20/2013 | US20130158049 7-azaindole inhibitors of crac |
| 06/20/2013 | US20130158043 Pak inhibitors for the treatment of cancer |
| 06/20/2013 | US20130158042 Novel compounds |
| 06/20/2013 | US20130158027 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 06/20/2013 | US20130158019 Pyrimidine compounds that inhibit anaplastic lymphoma kinase |
| 06/20/2013 | US20130158018 Heteroaryl Nitrile Compounds Useful as Inhibitors of Cathepsin-S |
| 06/20/2013 | US20130158003 Heteroaryl compounds and methods of use thereof |
| 06/20/2013 | US20130158002 Positive allosteric modulators of mglur2 |
| 06/20/2013 | US20130157996 Trpm8 antagonists and their use in treatments |
| 06/20/2013 | US20130156826 Respiratory formulations and compounds for use therein |
| 06/20/2013 | US20130156756 Substituted Triazolopyridines |
| 06/20/2013 | CA2857749A1 Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof |
| 06/19/2013 | EP2604608A2 Method for producing methyl- {4,6-diamino-2-[1-(2-fluorobenzyl) -1H-pyrazolo[3,4-b]pyridin-3-yl]-pyrimidin-5-yl}-methyl carbamate and its purification for its use as a pharmaceutical agent |
| 06/19/2013 | EP2604607A1 Prophylactic or therapeutic agent for non-alcoholic steatohepatitis |
| 06/19/2013 | EP2603510A1 New azacyclic compounds |
| 06/19/2013 | EP2603509A1 Crystalline form of pyrimidio[6,1-a]isoquinolin-4-one compound |
| 06/19/2013 | EP2603081A1 Besylate salt of a btk inhibitor |
| 06/19/2013 | EP2603079A1 Positive allosteric modulators of mglur2 |